| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 309-317, Copyright © 1993 by Endocrine Society
ARTICLES |
BA Bengtsson, S Eden, L Lonn, H Kvist, A Stokland, G Lindstedt, I Bosaeus, J Tolli, L Sjostrom and OG Isaksson
Department of Medicine, Sahlgrenska Hospital, Medical Faculty, University of Goteborg, Sweden.
In a double blind, cross-over placebo-controlled trial, we studied the effects of 26 weeks of replacement therapy with recombinant human GH on body composition, metabolic parameters, and well-being in 10 patients with adult-onset GH deficiency (GHD). All patients received appropriate thyroid, adrenal, and gonadal replacement therapy. The dose of recombinant human GH was 0.25-0.5 U/kg.week (0.013-0.026 mg/kg.day) and was administered sc daily at bedtime. One patient was withdrawn from the study because of edema and atrial fibrillation. Body composition was estimated with three independent methods: computed tomography, bioelectric impedance, and total body potassium combined with total body water assessments. The Comprehensive Psychological Rating Scale and the Symptom Check List-90 were used to assess any change in psychopathology. After 26 weeks of treatment, adipose tissue (AT) mass decreased 4.7 kg (P < 0.001). Subcutaneous AT decreased by an average of 13%, whereas visceral AT was reduced by 30%. Muscle volume increased by 2.5 kg (5%; P < 0.05). According to the four-compartment model derived from assessments of total body potassium and total body water, body cell mass and extracellular fluid volume increased significantly by 1.6 and 3.0 kg, whereas body fat decreased by 6.1 kg. Results obtained by the bioelectric impedance technique were similar. The mean (+/- SD) concentrations of insulin-like growth factor-I increased from 0.26 (0.06) at baseline to 2.56 (1.55) and 2.09 (1.03) kU/L after 6 and 26 weeks of treatment. Calcium and serum phosphate, osteocalcin, and procollagen-III concentrations were significantly higher, and intact PTH concentrations were reduced after 6 and 26 weeks of treatment, respectively. Total and free T3 concentrations were significantly increased after 6 and 26 weeks of treatment, whereas free T4 concentrations were reduced at 6 weeks, but after 26 weeks, free T4 concentrations had returned to pretreatment values. Finally, after 26 weeks of treatment, there was a decrease in the Comprehensive Psychological Rating Scale score (P < 0.05). The results show that GH replacement in GHD adults results in marked alterations in body composition, fat distribution, and bone and mineral metabolism and reduces psychiatric symptoms. Finally, we conclude that the observed beneficial effects of replacement therapy with GH are of sufficient magnitude to consider treatment of GHD adults.
This article has been cited by other articles:
![]() |
P. Touraine, G. A D'Souza, I. Kourides, R. Abs, P. Barclay, R. Xie, A. Pico, E. Torres-Vela, B. Ekman, and the GH Lipoatrophy Study Group Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH Eur. J. Endocrinol., October 1, 2009; 161(4): 533 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fernandez, M. Brada, L. Zabuliene, N. Karavitaki, and J. A H Wass Radiation-induced hypopituitarism Endocr. Relat. Cancer, September 1, 2009; 16(3): 733 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fanciulli, A. Delitala, and G. Delitala Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone Hum. Reprod. Update, May 1, 2009; 15(3): 341 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
N D. Aberg, I. Johansson, M. A I Aberg, J. Lind, U. E Johansson, C. M Cooper-Kuhn, H G. Kuhn, and J. Isgaard Peripheral administration of GH induces cell proliferation in the brain of adult hypophysectomized rats J. Endocrinol., April 1, 2009; 201(1): 141 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Webb, C. J. Strasburger, D. Mo, M. L. Hartman, S. Melmed, H. Jung, W. F. Blum, A. F. Attanasio, and on behalf of the HypoCCS International Advisory Bo Changing Patterns of the Adult Growth Hormone Deficiency Diagnosis Documented in a Decade-Long Global Surveillance Database J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 392 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bredella, A. L. Utz, M. Torriani, B. Thomas, D. A. Schoenfeld, and K. K. Miller Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis J Appl Physiol, February 1, 2009; 106(2): 418 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nass, S. S. Pezzoli, M. C. Oliveri, J. T. Patrie, F. E. Harrell Jr., J. L. Clasey, S. B. Heymsfield, M. A. Bach, M. L. Vance, and M. O. Thorner Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial Ann Intern Med, November 4, 2008; 149(9): 601 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lo, S. M. You, B. Canavan, J. Liebau, G. Beltrani, P. Koutkia, L. Hemphill, H. Lee, and S. Grinspoon Low-Dose Physiological Growth Hormone in Patients With HIV and Abdominal Fat Accumulation: A Randomized Controlled Trial JAMA, August 6, 2008; 300(5): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. U. Freda, W. Shen, S. B. Heymsfield, C. M. Reyes-Vidal, E. B. Geer, J. N. Bruce, and D. Gallagher Lower Visceral and Subcutaneous but Higher Intermuscular Adipose Tissue Depots in Patients with Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2334 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beauregard, A. L. Utz, A. E. Schaub, L. Nachtigall, B. M. K. Biller, K. K. Miller, and A. Klibanski Growth Hormone Decreases Visceral Fat and Improves Cardiovascular Risk Markers in Women with Hypopituitarism: A Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2063 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Svensson, N. Bucht, M. Hallberg, and F. Nyberg From the Cover: Reversal of opiate-induced apoptosis by human recombinant growth hormone in murine foetus primary hippocampal neuronal cell cultures PNAS, May 20, 2008; 105(20): 7304 - 7308. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu, B. Roberts, E. Bendavid, O. Saynina, S. R. Salpeter, A. M. Garber, et al. Systematic Review: The Effects of Growth Hormone on Athletic Performance Ann Intern Med, May 20, 2008; 148(10): 747 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klose, T. Watt, J. Brennum, and U. Feldt-Rasmussen Posttraumatic Hypopituitarism Is Associated with an Unfavorable Body Composition and Lipid Profile, and Decreased Quality of Life 12 Months after Injury J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3861 - 3868. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, A. Tivesten, K. Sjogren, O. Isaksson, G. Bergstrom, S. Mohan, J. Molne, J. Isgaard, and C. Ohlsson Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression J. Endocrinol., June 1, 2007; 193(3): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Davies, E. F. Gevers, A. E. Stevenson, K. T. Coschigano, M. M. El-Kasti, M. J. Bull, C. Elford, B. A. J. Evans, J. J. Kopchick, and T. Wells Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1483 - E1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ciresi, M C Amato, A Criscimanna, A Mattina, C Vetro, A Galluzzo, G D'Acquisto, and C Giordano Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency Eur. J. Endocrinol., March 1, 2007; 156(3): 353 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, D. M. Bravata, I. Olkin, S. Nayak, B. Roberts, A. M. Garber, and A. R. Hoffman Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly Ann Intern Med, January 16, 2007; 146(2): 104 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawai, N. Namba, S. Mushiake, Y. Etani, R. Nishimura, M. Makishima, and K. Ozono Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPAR{gamma} pathway J. Mol. Endocrinol., January 1, 2007; 38(1): 19 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koltowska-Haggstrom, A. F Mattsson, J. P Monson, P. Kind, X. Badia, F. F Casanueva, J. Busschbach, H. P F Koppeschaar, and G. Johannsson Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? Eur. J. Endocrinol., July 1, 2006; 155(1): 109 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Saugy, N Robinson, C Saudan, N Baume, L Avois, and P Mangin Human growth hormone doping in sport Br. J. Sports Med., July 1, 2006; 40(suppl_1): i35 - i39. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Saller, A. F Mattsson, P. H Kann, H. P Koppeschaar, J. Svensson, M. Pompen, and M. Koltowska-Haggstrom Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults - comparison between Sweden, The Netherlands and Germany. Eur. J. Endocrinol., June 1, 2006; 154(6): 843 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Svensson, M Diez, J Engel, C Wass, A Tivesten, J-O Jansson, O Isaksson, T Archer, T Hokfelt, and C Ohlsson Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J. Endocrinol., June 1, 2006; 189(3): 617 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Menezes Oliveira, C. Marques-Santos, J. A. Barreto-Filho, R. Ximenes Filho, A. V. de Oliveira Britto, A. H. Oliveira Souza, C. M. Prado, C. R. Pereira Oliveira, R. M. C. Pereira, T. de Almeida Ribeiro Vicente, et al. Lack of Evidence of Premature Atherosclerosis in Untreated Severe Isolated Growth Hormone (GH) Deficiency due to a GH-Releasing Hormone Receptor Mutation J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2093 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Berryman, E. O. List, D. T. Kohn, K. T. Coschigano, R. J. Seeley, and J. J. Kopchick Effect of Growth Hormone on Susceptibility to Diet-Induced Obesity Endocrinology, June 1, 2006; 147(6): 2801 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults Endocr. Rev., May 1, 2006; 27(3): 287 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Molitch, D. R. Clemmons, S. Malozowski, G. R. Merriam, S. M. Shalet, M. L. Vance, and for The Endocrine Society's Clinical Guidelines Su Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1621 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koranyi, I. Bosaeus, M. Alpsten, B.-A. Bengtsson, and G. Johannsson Body composition during GH replacement in adults - methodological variations with respect to gender. Eur. J. Endocrinol., April 1, 2006; 154(4): 545 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Egecioglu, M. Bjursell, A. Ljungberg, S. L. Dickson, J. J. Kopchick, G. Bergstrom, L. Svensson, J. Oscarsson, J. Tornell, and M. Bohlooly-Y Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E317 - E325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mukherjee, J. E Adams, L. Smethurst, and S. M Shalet Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults Eur. J. Endocrinol., November 1, 2005; 153(5): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bollerslev, J. Hallen, K. J Fougner, A. P. Jorgensen, C. Kristo, H. Fagertun, O. Gudmundsen, P. Burman, and T. Schreiner Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial Eur. J. Endocrinol., September 1, 2005; 153(3): 379 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, B. Soderpalm, K. Sjogren, J. Engel, and C. Ohlsson Liver-derived IGF-I regulates exploratory activity in old mice Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E466 - E473. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Esposito, S. G. Thomas, L. Kingdon, and S. Ezzat Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E494 - E503. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chihara, E. Koledova, A. Shimatsu, Y. Kato, H. Kohno, T. Tanaka, A. Teramoto, P. C Bates, and A. F Attanasio An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency Eur. J. Endocrinol., July 1, 2005; 153(1): 57 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mauras, O. H. Pescovitz, V. Allada, M. Messig, M. P. Wajnrajch, B. Lippe, and on behalf of the Transition Study Group Limited Efficacy of Growth Hormone (GH) during Transition of GH-Deficient Patients from Adolescence to Adulthood: A Phase III Multicenter, Double-Blind, Randomized Two-Year Trial J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3946 - 3955. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. White, A. M. Ahmad, B. H. Durham, A. Patwala, P. Whittingham, W. D. Fraser, and J. P. Vora Growth Hormone Replacement Is Important for the Restoration of Parathyroid Hormone Sensitivity and Improvement in Bone Metabolism in Older Adult Growth Hormone-Deficient Patients J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3371 - 3380. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Misra, K. K. Miller, C. Almazan, M. Worley, D. B. Herzog, and A. Klibanski Hormonal Determinants of Regional Body Composition in Adolescent Girls with Anorexia Nervosa and Controls J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2580 - 2587. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koutkia, B. Canavan, J. Breu, and S. Grinspoon Effects of Growth Hormone-Releasing Hormone on Bone Turnover in Human Immunodeficiency Virus-Infected Men with Fat Accumulation J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2154 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Franco, J. Brandberg, L. Lonn, B. Andersson, B.-A. Bengtsson, and G. Johannsson Growth Hormone Treatment Reduces Abdominal Visceral Fat in Postmenopausal Women with Abdominal Obesity: A 12-Month Placebo-Controlled Trial J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1466 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Miller, B. M. K. Biller, J. G. Lipman, G. Bradwin, N. Rifai, and A. Klibanski Truncal Adiposity, Relative Growth Hormone Deficiency, and Cardiovascular Risk J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Healy, R. Dall, J. Gibney, E. Bassett, C. Ehrnborg, C. Pentecost, T. Rosen, A. Cittadini, R. C. Baxter, and P. H. Sonksen Toward the Development of a Test for Growth Hormone (GH) Abuse: A Study of Extreme Physiological Ranges of GH-Dependent Markers in 813 Elite Athletes in the Postcompetition Setting J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L Boguszewski, L. H F Meister, D. C T Zaninelli, and R. B Radominski One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults Eur. J. Endocrinol., January 1, 2005; 152(1): 67 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bohlooly-Y, B. Olsson, C. E.G. Bruder, D. Linden, K. Sjogren, M. Bjursell, E. Egecioglu, L. Svensson, P. Brodin, J. C. Waterton, et al. Growth Hormone Overexpression in the Central Nervous System Results in Hyperphagia-Induced Obesity Associated With Insulin Resistance and Dyslipidemia Diabetes, January 1, 2005; 54(1): 51 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ameen, D. Linden, B.-M. Larsson, A. Mode, A. Holmang, and J. Oscarsson Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1039 - E1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Esposito, S. G. Thomas, L. Kingdon, and S. Ezzat Growth Hormone Treatment Improves Peripheral Muscle Oxygen Extraction-Utilization during Exercise in Patients with Human Immunodeficiency Virus-Associated Wasting: A Randomized Controlled Trial J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5124 - 5131. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koutkia, B. Canavan, J. Breu, M. Torriani, J. Kissko, and S. Grinspoon Growth Hormone-Releasing Hormone in HIV-Infected Men With Lipodystrophy: A Randomized Controlled Trial JAMA, July 14, 2004; 292(2): 210 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hoffman, C. J. Strasburger, A. Zagar, W. F. Blum, A. Kehely, and M. L. Hartman Efficacy and Tolerability of an Individualized Dosing Regimen for Adult Growth Hormone Replacement Therapy in Comparison with Fixed Body Weight-Based Dosing J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3224 - 3233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Harman and M. R. Blackman Hormones and Supplements: Do They Work?: Use of Growth Hormone for Prevention or Treatment of Effects of Aging J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): B652 - B658. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hoffman, J. E. Kuntze, J. Baptista, H. B. A. Baum, G. P. Baumann, B. M. K. Biller, R. V. Clark, D. Cook, S. E. Inzucchi, D. Kleinberg, et al. Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2048 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayakawa, Y. Shimazaki, T. Tsushima, Y. Kato, K. Takano, K. Chihara, A. Shimatsu, and M. Irie Metabolic Effects of 20-Kilodalton Human Growth Hormone (20K-hGH) for Adults with Growth Hormone Deficiency: Results of an Exploratory Uncontrolled Multicenter Clinical Trial of 20K-hGH J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1562 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lall, N. Balthasar, D. Carmignac, C. Magoulas, A. Sesay, P. Houston, K. Mathers, and I. Robinson Physiological Studies of Transgenic Mice Overexpressing Growth Hormone (GH) Secretagogue Receptor 1A in GH-Releasing Hormone Neurons Endocrinology, April 1, 2004; 145(4): 1602 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Murray, B. Columb, J. E. Adams, and S. M. Shalet Low Bone Mass Is an Infrequent Feature of the Adult Growth Hormone Deficiency Syndrome in Middle-Age Adults and the Elderly J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1124 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Underwood, K. M. Attie, and J. Baptista Growth Hormone (GH) Dose-Response in Young Adults with Childhood-Onset GH Deficiency: A Two-Year, Multicenter, Multiple-Dose, Placebo-Controlled Study J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5273 - 5280. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kasukawa, D. J. Baylink, J. E. Wergedal, Y. Amaar, A. K. Srivastava, R. Guo, and S. Mohan Lack of Insulin-Like Growth Factor I Exaggerates the Effect of Calcium Deficiency on Bone Accretion in Mice Endocrinology, November 1, 2003; 144(11): 4682 - 4689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ahmad, J. Thomas, A. Clewes, M. T. Hopkins, R. Guzder, H. Ibrahim, B. H. Durham, J. P. Vora, and W. D. Fraser Effects of Growth Hormone Replacement on Parathyroid Hormone Sensitivity and Bone Mineral Metabolism J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2860 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, K. Stibrant Sunnerhagen, and G. Johannsson Five Years of Growth Hormone Replacement Therapy in Adults: Age- and Gender-Related Changes in Isometric and Isokinetic Muscle Strength J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2061 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gibney, M. L. Healy, M. Stolinski, S. B. Bowes, C. Pentecost, L. Breen, C. McMillan, D. L. Russell-Jones, P. H. Sonksen, and A. M. Umpleby Effect of Growth Hormone (GH) on Glycerol and Free Fatty Acid Metabolism during Exhaustive Exercise in GH-Deficient Adults J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1792 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gianotti, S. Pivetti, F. Lanfranco, F. Tassone, F. Navone, E. Vittori, R. Rossetto, C. Gauna, S. Destefanis, S. Grottoli, et al. Concomitant Impairment of Growth Hormone Secretion and Peripheral Sensitivity in Obese Patients with Obstructive Sleep Apnea Syndrome J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5052 - 5057. [Abstract] [Full Text] [PDF] |
||||
![]() |
Why start an adult on growth hormone? DTB, October 1, 2002; 40(10): 75 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Cook, B. M. K. Biller, M. L. Vance, A. R. Hoffman, L. S. Phillips, K. M. Ford, D. P. Benziger, A. Illeperuma, S. L. Blethen, K. M. Attie, et al. The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4508 - 4514. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Isley Growth Hormone Therapy for Adults: Not Ready for Prime Time? Ann Intern Med, August 6, 2002; 137(3): 190 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Cook Shouldn't Adults with Growth Hormone Deficiency Be Offered Growth Hormone Replacement Therapy? Ann Intern Med, August 6, 2002; 137(3): 197 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ezzat, S. Fear, R.-C. Gaillard, C. Gayle, H. Landy, S. Marcovitz, T. Mattioni, S. Nussey, A. Rees, and E. Svanberg Gender-Specific Responses of Lean Body Composition and Non-Gender-Specific Cardiac Function Improvement after GH Replacement in GH-Deficient Adults J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2725 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Le Greves, P. Steensland, P. Le Greves, and F. Nyberg Growth hormone induces age-dependent alteration in the expression of hippocampal growth hormone receptor and N-methyl-D-aspartate receptor subunits gene transcripts in male rats PNAS, May 14, 2002; 99(10): 7119 - 7123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kehely, P. C. Bates, P. Frewer, M. Birkett, W. F. Blum, P. Mamessier, S. Ezzat, K. K. Y. Ho, G. Lombardi, A. Luger, et al. Short-Term Safety and Efficacy of Human GH Replacement Therapy in 595 Adults with GH Deficiency: A Comparison of Two Dosage Algorithms J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 1974 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, J. Fowelin, K. Landin, B.-A. Bengtsson, and J.-O. Johansson Effects of Seven Years of GH-Replacement Therapy on Insulin Sensitivity in GH-Deficient Adults J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2121 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Johannsson, Y. B. Sverrisdottir, L. Ellegard, P.-A. Lundberg, and H. Herlitz GH Increases Extracellular Volume by Stimulating Sodium Reabsorption in the Distal Nephron and Preventing Pressure Natriuresis J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1743 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Frajese, W. M. Drake, R. A. Loureiro, J. Evanson, D. Coyte, D. F. Wood, A. B. Grossman, G. M. Besser, and J. P. Monson Hypothalamo-Pituitary Surveillance Imaging in Hypopituitary Patients Receiving Long-Term GH Replacement Therapy J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5172 - 5175. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hernberg-Stahl, A. Luger, R. Abs, B.-A. Bengtsson, U. Feldt-Rasmussen, P. Wilton, B. Westberg, and J. P. Monson Healthcare Consumption Decreases in Parallel with Improvements in Quality of Life during GH Replacement in Hypopituitary Adults with GH Deficiency J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5277 - 5281. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. McConnell, A. B. Atkinson, C. Ennis, D. R. Hadden, D. R. McCance, B. Sheridan, and P. M. Bell The Effects on Insulin Action in Adult Hypopituitarism of Recombinant Human GH Therapy Individually Titrated for Six Months J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5342 - 5347. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gotherstrom, J. Svensson, J. Koranyi, M. Alpsten, I. Bosaus, B.-A. Bengtsson, and G. Johannsson A Prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic Indices J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4657 - 4665. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hulthen, B.-A. Bengtsson, K. S. Sunnerhagen, L. Hallberg, G. Grimby, and G. Johannsson GH Is Needed for the Maturation of Muscle Mass and Strength in Adolescents J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4765 - 4770. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bohlooly-Y, B. Ola, A. Gritli-Linde, O. Brusehed, O. G. P. Isaksson, C. Ohlsson, B. Soderpalm, and J. Tornell Enhanced Spontaneous Locomotor Activity in Bovine GH Transgenic Mice Involves Peripheral Mechanisms Endocrinology, October 1, 2001; 142(10): 4560 - 4567. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet Optimizing GH Therapy in Adults and Children Endocr. Rev., August 1, 2001; 22(4): 425 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wiren, G. Johannsson, and B.-A. Bengtsson A Prospective Investigation of Quality of Life and Psychological Well-Being after the Discontinuation of GH Treatment in Adolescent Patients Who Had GH Deficiency during Childhood J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3494 - 3498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ahmad, R. Guzder, A. M. Wallace, J. Thomas, W. D. Fraser, and J. P. Vora Circadian and Ultradian Rhythm and Leptin Pulsatility in Adult GH Deficiency: Effects of GH Replacement J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3499 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Munzer, S. M. Harman, P. Hees, E. Shapiro, C. Christmas, M. F. Bellantoni, T. E. Stevens, K. G. O'Connor, K. M. Pabst, C. St. Clair, et al. Effects of GH and/or Sex Steroid Administration on Abdominal Subcutaneous and Visceral Fat in Healthy Aged Women and Men J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3604 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Clasey, A. Weltman, J. Patrie, J. Y. Weltman, S. Pezzoli, C. Bouchard, M. O. Thorner, and M. L. Hartman Abdominal Visceral Fat and Fasting Insulin Are Important Predictors of 24-Hour GH Release Independent of Age, Gender, and Other Physiological Factors J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3845 - 3852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Barkan The "Quality of Life-Assessment of Growth Hormone Deficiency in Adults" Questionnaire: Can It Be Used to Assess Quality of Life in Hypopituitarism? J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1905 - 1907. [Abstract] [Full Text] |
||||
![]() |
T. Laursen, C. H. Gravholt, L. Heickendorff, J. Drustrup, A.-M. Kappelgaard, J. O. L. Jørgensen, and J. S. Christiansen Long-Term Effects of Continuous Subcutaneous Infusion Versus Daily Subcutaneous Injections of Growth Hormone (GH) on the Insulin-Like Growth Factor System, Insulin Sensitivity, Body Composition, and Bone and Lipoprotein Metabolism in GH-Deficient Adults J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1222 - 1228. [Abstract] [Full Text] |
||||
![]() |
B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text] |
||||
![]() |
A. M. Rosenfalck, S. Maghsoudi, S. Fisker, J. O. L. Jørgensen, J. S. Christiansen, J. Hilsted, A. Vølund, and S. Madsbad The Effect of 30 Months of Low-Dose Replacement Therapy with Recombinant Human Growth Hormone (rhGH) on Insulin and C-Peptide Kinetics, Insulin Secretion, Insulin Sensitivity, Glucose Effectiveness, and Body Composition in GH-Deficient Adults J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4173 - 4181. [Abstract] [Full Text] |
||||
![]() |
G. Amato, G. Mazziotti, C. Di Somma, E. Lalli, G. De Felice, M. Conte, M. Rotondi, M. Pietrosante, G. Lombardi, A. Bellastella, et al. Recombinant Growth Hormone (GH) Therapy in GH-Deficient Adults: A Long-Term Controlled Study on Daily Versus Thrice Weekly Injections J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3720 - 3725. [Abstract] [Full Text] |
||||
![]() |
A. Chrisoulidou, S. A. Beshyah, O. Rutherford, T. J. Spinks, J. Mayet, P. Kyd, V. Anyaoku, A. Haida, B. Ariff, M. Murphy, et al. Effects of 7 Years of Growth Hormone Replacement Therapy in Hypopituitary Adults J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3762 - 3769. [Abstract] [Full Text] |
||||
![]() |
N. D. Aberg, B. Carlsson, L. Rosengren, J. Oscarsson, O. G. P. Isaksson, L. Ronnback, and P. S. Eriksson Growth Hormone Increases Connexin-43 Expression in the Cerebral Cortex and Hypothalamus Endocrinology, October 1, 2000; 141(10): 3879 - 3886. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sesmilo, B. M.K. Biller, J. Llevadot, D. Hayden, G. Hanson, N. Rifai, and A. Klibanski Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency: A Randomized, Controlled Clinical Trial Ann Intern Med, July 18, 2000; 133(2): 111 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vahl, A. Juul, J. O. L. Jørgensen, H. Ørskov, N. E. Skakkebæk, and Jens. S. Christiansen Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled Study J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1874 - 1881. [Abstract] [Full Text] |
||||
![]() |
A. KAMEL, S. NORGREN, A. ELIMAM, P. DANIELSSON, and C. MARCUS Effects of Growth Hormone Treatment in Obese Prepubertal Boys J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1412 - 1419. [Abstract] [Full Text] |
||||
![]() |
B.-A. Bengtsson and G. Johannsson The Treatment of Growth Hormone Deficiency in Adults J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 933 - 937. [Full Text] |
||||
![]() |
B. M. K. Biller, G. Sesmilo, H. B. A. Baum, D. Hayden, D. Schoenfeld, and A. Klibanski Withdrawal of Long-Term Physiological Growth Hormone (GH) Administration: Differential Effects on Bone Density and Body Composition in Men with Adult-Onset GH Deficiency J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 970 - 976. [Abstract] [Full Text] |
||||
![]() |
B. Bülow, L. Hagmar, J. Eskilsson, and E. M. Erfurth Hypopituitary Females Have a High Incidence of Cardiovascular Morbidity and an Increased Prevalence of Cardiovascular Risk Factors J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 574 - 584. [Abstract] [Full Text] |
||||
![]() |
M. Ottosson, P. Lönnroth, P. Björntorp, and S. Edén Effects of Cortisol and Growth Hormone on Lipolysis in Human Adipose Tissue J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 799 - 803. [Abstract] [Full Text] |
||||
![]() |
J. D. Wallace, R. C. Cuneo, P. A. Lundberg, T. Rosén, J. O. L. Jørgensen, S. Longobardi, N. Keay, L. Sacca, J. S. Christiansen, B.-A. Bengtsson, et al. Responses of Markers of Bone and Collagen Turnover to Exercise, Growth Hormone (GH) Administration, and GH Withdrawal in Trained Adult Males J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 124 - 133. [Abstract] [Full Text] |
||||
![]() |
G. A. Bray and F. L. Greenway Current and Potential Drugs for Treatment of Obesity Endocr. Rev., December 1, 1999; 20(6): 805 - 875. [Abstract] [Full Text] |
||||
![]() |
Discontinuation of Growth Hormone (GH) Treatment: Metabolic Effects in GH-Deficient and GH-Sufficient Adolescent Patients Compared with Control Subjects J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4516 - 4524. [Abstract] [Full Text] |
||||
![]() |
B. Söderpalm, M. Ericson, M. Bohlooly-y, J. A. Engel, and J. Törnell Bovine Growth Hormone Transgenic Mice Display Alterations in Locomotor Activity and Brain Monoamine Neurochemistry Endocrinology, December 1, 1999; 140(12): 5619 - 5625. [Abstract] [Full Text] |
||||
![]() |
B.-A. Bengtsson, R. Abs, H. Bennmarker, J. P. Monson, U. Feldt-Rasmussen, E. Hernberg-Ståhl, B. Westberg, P. Wilton, and C. Wüster The Effects of Treatment and the Individual Responsiveness to Growth Hormone (GH) Replacement Therapy in 665 GH-Deficient Adults J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3929 - 3935. [Abstract] [Full Text] |
||||
![]() |
A. Colao, A. Cuocolo, C. Di Somma, G. Cerbone, A. M. Della Morte, E. Nicolai, R. Lucci, M. Salvatore, and G. Lombardi Impaired Cardiac Performance in Elderly Patients with Growth Hormone Deficiency J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3950 - 3955. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |